688131 皓元醫藥
按盤價 
85.620 -2.760 (-3.123%) | 2025/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 1,310,943 | 24.20% | 2,270,178 | 1,880,047 | 1,358,054 | 969,226 | |
| 減：營業總成本 | 1,083,753 | 17.88% | 1,900,882 | 1,672,707 | 1,144,721 | 740,797 | |
| 其中:營業成本 | 667,675 | 15.80% | 1,181,279 | 1,030,874 | 659,411 | 444,701 | |
| 財務費用 | 16,689 | 22.95% | 34,516 | 31,850 | (578) | 6,241 | |
| 資產減值損失 | (60,967) | 22.17% | (131,360) | (83,999) | (43,376) | (29,089) | |
| 公允價值變動收益 | 213 | -- | 150 | -- | -- | -- | |
| 投資收益 | 1,247 | -123.78% | (13,758) | (4,772) | 16,053 | (119) | |
| 其中：對聯營企業和合營企業的投資收益 | (4,034) | -23.09% | (13,771) | (6,113) | (2,746) | (1,302) | |
| 營業利潤 | 184,724 | 135.39% | 236,817 | 128,329 | 196,567 | 209,752 | |
| 利潤總額 | 181,622 | 130.95% | 238,355 | 128,193 | 198,543 | 209,519 | |
| 減：所得稅費用 | 32,926 | 238.68% | 40,425 | 1,885 | 6,986 | 18,947 | |
| 淨利潤 | 148,696 | 115.76% | 197,930 | 126,308 | 191,558 | 190,572 | |
| 減：非控股權益 | (3,065) | 105.88% | (3,660) | (1,142) | (2,086) | (408) | |
| 股東淨利潤 | 151,761 | 115.55% | 201,590 | 127,449 | 193,643 | 190,980 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.720 | 118.18% | 0.960 | 0.610 | 1.330 | 2.100 | |
| 每股派息 (元) * | 0.080 | 100.00% | 0.190 | 0.150 | 0.380 | 0.530 | |
| 每股淨資產 (元) * | 13.885 | 11.53% | 13.109 | 16.684 | 21.690 | 24.512 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 30/10/2025 13:01 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
